# FDA 483 - Biovectra, Inc. - April 19, 2024

Source: https://www.globalkeysolutions.net/records/483/biovectra-inc/f876d21b-ffcd-4001-af36-2c6b587572d0

> FDA 483 for Biovectra, Inc. on April 19, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Biovectra, Inc.
- Inspection Date: 2024-04-19
- Product Type: drugs
- Office Name: Division of Biotechnology Manufacturing

## Related Documents

- [483 - 2017-02-17](https://www.globalkeysolutions.net/records/483/biovectra-inc/773a5858-5c4c-456e-bdf5-e703c5faaff7)
- [483 - 2022-08-26](https://www.globalkeysolutions.net/records/483/biovectra-inc/a9e6f5c1-5f2f-405e-8e41-a3422f6d1306)

## Related Officers

- [Jose M. Cayuela](https://www.globalkeysolutions.net/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)

Company: https://www.globalkeysolutions.net/companies/biovectra-inc/1e29a998-319e-49cb-bee2-bacea2c620ef

Office: https://www.globalkeysolutions.net/offices/division-of-biotechnology-manufacturing/3e3018f1-aa48-4010-a554-96f557f17c55